The Power of Experience


  • Feiss G., Morris R., Rom D. et al. (1992). A comparative study of the effects of intranasal triamcinolone acetonide (ITAA) and prednisone on adrenocortical function. The Journal of Allergy and Clinical Immunology, 89(6), 1151-1156.
  • Howland WC, Dockhorn R, Gillman S, Gross GN, Hille D, Simpson B, Furst JA, Feiss G, Smith JA. A comparision of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis. J of Allergy Asthma Immunol. 1996; July: 98(1): 32-38.
  • Munk ZM, LaForce C, Furst JA, Simpson B, Feiss G, Smith JA. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1996; Oct: 77(4): 277-81- Study RG 5029Y-301.
  • Banov CH, Silvers WS, Green AW, van Bavel JH, Winder JA, Feiss G, Simpson B, Furst JA, Smith JA.  Placebo-controlled, double-blind study of the efficacy of triamcinolone acetone aerosol nasal inhaler in pediatric patients with seasonal allergic rhinitis.  Clin Ther.  1996 Mar-Apr; 18(2):265-72.- Study RG 5029-121.
  • Storms WW, Southern DL, Feiss, G, Simpson B, Furst JA, Smith JA.  Efficacy of triamcinolone acetonide aerosol nasal inhaler in children with perennial allergic rhinitis.  Pediatric Asthma, Allergy & Immunology (submitted 3/96). – Study 5029-120.
  • Gross, G, Boggs, P, Ginchansky E, Howland W, Munk Z, Weakley S, Alderfer V, Simpson B, Feiss, G, Furst JA, Smith JA.  A placebo-controlled double-blind comparison of topical versus systemic triamcinolone aqueous nasal spray in seasonal allergic rhinitis.  AM J of Rhinology (submitted 12/95). – Study RG 5029Y-308.
  • Smith JA, Beaucher WN, Kobayashi RH, Koepke JW, Ransom JH, Rosen JP, Feiss G, Furst JA, Simpson B.  Long-term safety and efficacy of triamcinolone acetonide aqueous nasal spray for the treatment of perennial allergic rhinitis.  Allergy Asthma Proc 1997 Jan-Feb; 18(1):33-7 Study RG 5029Y-305LT.
  • Smith JA, Schenkel E, Gross G, Jacobson K, Kobayashi R, Settipane G, Feiss G, Furst J, Simpson B.  Efficacy and safety of once-daily triamcinolone acetonide aqueous nasal spray in pediatric patients with spring grass seasonal allergic rhinitis.  J of Allergy and Clinical Immunology 1996; 97:197 (No. 1 Pt. 3).  Abstracts. – RG 5029Y-312.
  • LaForce K, Hampel F, Kiechel F, Lumry W, Murray J, Furst JA, Simpson B, Smith JA. Comparison of once-daily triamcinolone acetonide aqueous nasal spray and twice –daily Beconase AQ® for the treatment of seasonal allergic rhinitis due to ragweed.  J of Allergy and Clinical Immunology. 1996; 97:433 (No. 1, Pt. 3).  Abstract. – Study RG 5029Y-406.
  • Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol. 1999
  • Nelson HS, Busse WW, deBoisblanc BP, Berger WE, Noonan MJ, Webb DR, Wolford JP, Mahajan PS, Hamedani AG, Shah T, Harding SM. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma. J Allergy Clin Immunol. 1999 Feb;103(2 Pt 1):267-75
  • Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma. J Allergy Clin Immunol. 1998 Jul;102(1):32-8.
  • Pearlman DS, Noonan MJ, Tashkin DP, Goldstein MF, Hamedani AG, Kellerman DJ, Schaberg A. Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma. Ann Allergy Asthma Immunol. 1997 Apr;78(4):356-62.
  • Contact Us

    ✆ Business inquiries?